Visus Therapeutics, Inc.
Industry
- Biotechnology
- Pharmaceuticals
- Drug Delivery
- Topical Delivery
- Vaccines
- Drug Delivery
Other Names/Subsidiaries
- Viewpoint Therapeutics
Latest on Visus Therapeutics, Inc.
AbbVie Inc. will have direct competition for its presbyopia product Vuity, since privately held Orasis Pharmaceuticals Ltd. got US Food and Drug Administration approval for the same indication on 1
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. BMS Calls On SyntheX, Autolus In Protei
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Taiho To Pay $275m Up Front For CLN-081
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Visus Licenses Drugs From Cella, Delive